SCHEMBL5319455

SCHEMBL5319455

CC(Nc1c(O)cccc1O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.46
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA7 P43166 3/20 0.46
CA9 Q16790 3/20 0.46
CA14 Q9ULX7 3/20 0.46
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
TAS1R2 Q8TE23 1/20 0.42
KMT2A Q03164 1/20 0.40
THRB P10828 1/20 0.39
MCL1 Q07820 2/20 0.39
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC8 Q9BY41 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5319450 1.00 CA12 (0.46) CA12CA1CA2CA7CA9
SCHEMBL4411485 0.80 POLB (0.43) LMNAALDH1A1KMT2AHDAC4HDAC7
SCHEMBL1900149 0.80 POLB (0.43) LMNAALDH1A1KMT2AHDAC4HDAC7
SCHEMBL4411484 0.80 POLB (0.43) LMNAALDH1A1KMT2AHDAC4HDAC7
SCHEMBL6264012 0.80 POLB (0.43) LMNAALDH1A1KMT2AHDAC4HDAC7
SCHEMBL5323263 0.79 LMNA (0.41) CA12CA1CA2CA7CA9
SCHEMBL1627872 0.79 LMNA (0.41) CA12CA1CA2CA7CA9
SCHEMBL5323369 0.78 HPGD (0.49) LMNAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL5323373 0.78 HPGD (0.49) LMNAKDM4EALDH1A1HPGDHSD17B10
Hydrochloric Acid SCHEMBL14988824 0.78 POLB (0.42) LMNAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070258899-A1 Diagnostic and therapeutic agents KARYON-CTT LTD (FI) 2007-11-08 US disclosed
WO-2007113385-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258899-A1 Diagnostic and therapeutic agents YBX1, MLX, TPX2 CA12 1688/4885CA1 3341/4885CA2 2109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.